🔎 Trials Near Me

Почетна › Метастатски карцином › Калифорнија › Los Angeles

Клинички испитувања за Метастатски карцином во Los Angeles, CA

57 студии за Метастатски карцином бараат учесници на локации во и околу Los Angeles (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Се регрутираФаза 2
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Се регрутираФаза 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Се регрутираФаза 1/2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Се регрутираФаза 1
  • Cedars-Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06234605

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Се регрутираФаза 1
  • University of California - Los Angeles, Los Angeles
Возраст 19 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06586957

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Се регрутираФаза 1
  • University of California Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06625775

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Се регрутираФаза 2/3
  • Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT06943755

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Се регрутираФаза 1/2
  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
До возраст 25 · Сите полови · Ажурирано 25.9.2026 · NCT04094610

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Се регрутираФаза 2/3
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Се регрутираФаза 3
  • Oncura Health - Good Samaritan, Los Angeles
  • California Research Institute, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566

Intratumoral N17350 in Advanced Solid Tumors

Се регрутираФаза 1/2
  • The Angeles Clinic and Research Institute, Los Angeles
  • UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07339176

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Се регрутираФаза 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT06915753

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Се регрутираФаза 3
  • UCLA Hematology/Oncology - Westwood (Building 100), Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Се регрутираФаза 3
  • TRIO-US (Translational Research in Oncology-US), Los Angeles
  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Се регрутираФаза 3
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07174336

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Се регрутираФаза 1/2
  • California Research Institute (CRI), Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07262619

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Се регрутираФаза 1/2
  • UCLA Hematology & Oncology ( Site 0003), Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06863272

CREO - Microwave Ablation Feasibility Study

Се регрутира
  • Cedars Sinai, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07817147

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Се регрутираФаза 1/2
  • Clinical Study Site, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT07335497

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06440005

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Се регрутираФаза 3
  • Cedars-Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Се регрутираФаза 1/2
  • Avenzo Therapeutics Recruiting Site, Los Angeles
  • Avenzo Therapeutics Recruiting Site, Los Angeles
Возраст од 18 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT07038343

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

Се регрутираФаза 1/2
  • START Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07602842

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Се регрутираФаза 3
  • Los Angeles Cancer Network, Los Angeles
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Facility, Los Angeles
  • Los Angeles Cancer Network_Century City, Los Angeles
  • и уште 3
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Се регрутираФаза 1
  • The Angeles Clinic, Los Angeles
  • UCLA, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT04913285

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Се регрутираФаза 2
  • University of California Los Angeles, Los Angeles
  • Samuel Oschin Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Се регрутираФаза 1
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT05614739

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Се регрутираФаза 2
  • Research Site, Los Angeles
Возраст од 18 до 130 · Сите полови · Ажурирано 18.8.2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Се регрутираФаза 1/2
  • University of California, Los Angeles (UCLA), Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264

A Study of MGC026 in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • The Angeles Clinic and Research Institute, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06242470

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Се регрутираФаза 1
  • START Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 10.8.2026 · NCT06880549

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Се регрутираФаза 1
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 3.8.2026 · NCT05687110

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Се регрутираФаза 1
  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Возраст 12 и постари · Сите полови · Ажурирано 31.7.2026 · NCT05372640

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Се регрутираФаза 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • The Angeles Clinic and Research Institute, Los Angeles
Возраст 12 и постари · Сите полови · Ажурирано 14.7.2026 · NCT05533697

A Study of PYX-201 in Advanced Solid Tumors

Се регрутираФаза 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 30.6.2026 · NCT05720117

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Се регрутираФаза 1
  • Cedars-Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07458347

REMASTer: REcurrent Brain Metastases After SRS Trial

Се регрутира
  • UCLA, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 18.6.2026 · NCT05124912

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Се регрутираФаза 2
  • VA Greater Los Angeles Healthcare System, Los Angeles
Возраст 18 и постари · Мажи · Ажурирано 15.6.2026 · NCT05422911

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Се регрутираФаза 1
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.6.2026 · NCT06917079

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Се регрутираФаза 3
  • UCLA Hematology Oncology Santa Monica, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 18.5.2026 · NCT06757634

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Се регрутираФаза 2/3
  • Helios Clinical Research, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 8.5.2026 · NCT06697301

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Се регрутираФаза 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 28.4.2026 · NCT06413680

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Се регрутираФаза 1/2
  • Cedars-Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.4.2026 · NCT07020221

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Се регрутираФаза 2/3
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 17.4.2026 · NCT06947928

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Се регрутираФаза 3
  • University of California Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 9.4.2026 · NCT06064877

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Се регрутираФаза 2/3
  • The Angeles Clinic and Research Institute, Los Angeles
  • University of California Los Angeles, Los Angeles
Сите возрасти · Сите полови · Ажурирано 2.4.2026 · NCT06581406

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Се регрутираФаза 2
  • USC/Norris Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 31.3.2026 · NCT06634875

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Се регрутираФаза 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 20.3.2026 · NCT05948865

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Се регрутираФаза 1
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Возраст од 18 до 75 · Сите полови · Ажурирано 17.3.2026 · NCT04119024

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Се регрутираФаза 1/2
  • Los Angeles General Medical Center, Los Angeles
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Возраст од 18 до 99 · Сите полови · Ажурирано 10.3.2026 · NCT04333706

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Се регрутира
  • Cedars-Sinai Medical Center, Los Angeles
Возраст од 18 до 99 · Сите полови · Ажурирано 20.2.2026 · NCT04907643

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Се регрутираФаза 1
  • USC - Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT06778863

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Се регрутираФаза 3
  • Usc Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 6.2.2026 · NCT06127407

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Се регрутираФаза 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2025 · NCT05808634

A Study of NX-1607 in Adults With Advanced Malignancies

Се регрутираФаза 1
  • University of Southern California, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT05107674

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Се регрутираФаза 1/2
  • University of Southern California, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2025 · NCT05394103

Испитувања за Метастатски карцином во други градови

Други студии во Los Angeles

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.